ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Thyroid Endocrinology
Microwave Ablation vs. Surgery for Thyroid Microcarcinoma Near the Capsule: A Propensity-Matched Study on Safety and Efficacy
Provisionally accepted
Yimei Deng
Yu Song*- the second hospital of dalian medical university, Daliam, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective Ultrasound-guided microwave ablation (MWA) has been widely used as an efficient and safe minimally invasive treatment for papillary thyroid microcarcinomas (PTMCs). However, controversy persists regarding its application for PTMCs adjacent to the thyroid capsule. This study aimed to compare the feasibility, efficacy, and safety of MWA versus surgery for US-detected PTMCs closely abutting the capsule. Materials and Methods This retrospective study included 364 PTMC patients from January 2019 to September 2024, comprising 69 in the MWA group and 295 in the surgical group. Propensity score matching (PSM) was used to balance baseline characteristics between groups. Based on maximum nodule diameter, patients were stratified into ≤5 mm and >5 mm subgroups. Primary outcomes included technical success, postoperative complications, and tumor progression; secondary outcomes encompassed changes in tumor size/volume and treatment-related variables (hospital stay, operative duration, estimated blood loss, and costs). Results After PSM, 94 patients underwent surgery (mean age 43.89±11.50 years) and 67 received MWA (mean age 45.27±10.66 years). Follow-up durations were 31.00±1.66 (MWA) and 31.57±16.00 months (surgery). Both groups achieved 100% technical success, with no significant difference in complication rates (3.0% vs. 3.3%, P = 1.000). Tumor progression occurred in one case per group (1.1% [1/94] vs. 1.5% [1/67], P > 0.05). Among surgery patients without preoperative US-detected lymph node metastasis (LNM), pathology revealed LNM in 40.4% (38/94), primarily in central compartments (86.8%, 33/38). However, only one surgical case (1.1%) exhibited LNM during follow-up, while no MWA patients developed LNM or required delayed surgery. Secondary outcomes favored MWA over surgery, showing shorter operative time (32.18±6.31 vs. 73.88±31.8 min, P < 0.001), less blood loss (1.94±0.42 vs. 14.73±14.03 mL, P < 0.001), reduced hospitalization (2.81±2.42 vs. 6.57±2.50 days, P < 0.001), and lower costs (17,013.57±3,975.02 vs. 26,610.61±4,474.84 CNY, P < 0.001). The cumulative tumor disappearance rate in the MWA group was 89.0%. Subgroup analyses revealed no significant differences in treatment variables, complications, or tumor volume reduction. Conclusion MWA demonstrates comparable short-term outcomes to surgery for PTMCs adjacent to the capsule, offering a safe and effective therapeutic alternative.
Keywords: thyroid papillary microcarcinoma, Microwave ablation, Treatment, Minimally invasive therapy, Propensity score matching
Received: 19 Aug 2025; Accepted: 05 Nov 2025.
Copyright: © 2025 Deng and Song. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yu Song, 19800309@sina.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.